Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,216 across all filing types
Latest filing 2013-05-10 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from the board of directors regarding the resignation of the Chief Financial Officer, Company Secretary, and Alternate Authorised Representative, and the appointment of a new person to these roles. It contains no financial data, no report or presentation, and is focused solely on management changes. This fits the category of Board/Management Information (MANG). The document length is short (2304 characters), and it is clearly an announcement of management changes rather than a report or other filing type.
2013-05-10 English
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
Regulatory Filings Classification · 95% confidence The document is an announcement pursuant to a specific listing rule (Rule 13.09(2)(a)) of the Hong Kong Stock Exchange. It discusses the status of regulatory approvals related to a disposal transaction and advises caution to shareholders. The document is relatively short (3295 characters) and does not contain financial statements or detailed financial data. It is an update on regulatory approval status rather than a full report or financial disclosure. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a management or board change announcement. It is not a voting result or dividend notice. The content is a regulatory announcement about a transaction approval process, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2013-05-06 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/4/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, which aligns with announcements about share issues or capital changes. Therefore, the document fits best under the category 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed data, confirming it is not a mere announcement or report publication notice.
2013-05-06 English
Proxy Form for Annual General Meeting 2013
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of a company, allowing shareholders to appoint a proxy to vote on their behalf on various resolutions including adoption of financial statements, re-election of directors, appointment of auditors, dividend declaration, and share issuance mandates. It is not the actual AGM materials or presentations, but a form used to facilitate voting at the AGM. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is about 5,085 characters, consistent with a proxy form. There is no financial data or report content, so it is not an Annual Report or other financial report. Therefore, the correct classification is PSI.
2013-04-11 English
PROPOSALS FOR RE-ELECTION OF DIRECTORS AND GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES AND DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular to shareholders of Lijun International Pharmaceutical (Holding) Co., Ltd. regarding the Annual General Meeting (AGM). It includes proposals for the re-election of directors, general mandates to issue and repurchase shares, declaration of final dividend, and the notice of the AGM itself. The text contains detailed information about the AGM agenda, proxy forms, voting procedures, and biographical details of directors proposed for re-election. It is not a financial report, earnings release, or audit report, but rather materials distributed to shareholders in connection with the AGM. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting.
2013-04-11 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Lijun International Pharmaceutical (Holding) Co., Ltd. It includes details about the meeting date, agenda items such as adoption of audited financial statements, re-election of directors, authorization of directors' remuneration, re-appointment of auditors, dividend declaration, and approval of share issuance and repurchase mandates. The document is clearly a formal notice inviting shareholders to attend the AGM and vote on various resolutions. It does not contain the actual financial statements or detailed financial performance data, but rather the agenda and procedural information for the meeting. Therefore, this document fits the category of AGM Information (AGM-R).
2013-04-11 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.